Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Novo Nordisk Farma Oy
Femme et Homme Max 99 ans
Novo Nordisk Farma Oy
MAJ Il y a 4 ans
A one-year, multi-national, open-labelled, parallel-group, 2:1 randomised treat-to-target trial comparing efficacy and safety of insulin detemir with insulin glargine using a basal-bolus regimen with insulin aspart as mealtime insulin in subjects with type 1 diabetes
To compare the glycaemic control of insulin detemir with that of insulin glargine as measured by HbA1c in subjects with type 1 diabetes on a basal-bolus regimen with insulin aspart as bolus insulin af...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Novo Nordisk Farma Oy
MAJ Il y a 4 ans
NordiNet International Outcome Study (NordiNet IOS)
To collect the post-marketing data on effectiviness and safety of real-life treatment with Norditropin.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Novo Nordisk Farma Oy
MAJ Il y a 4 ans
A one-year, multi-national, open-labelled, parallel-group, 2:1 randomised treat-to-target trial comparing efficacy and safety of insulin detemir with insulin glargine using a basal-bolus regimen with insulin aspart as mealtime insulin in subjects with type 2 diabetes
To compare the glycaemic control of insulin detemir with that of insulin glargine as measured by HbA1c in subjects with type 2 diabetes on a basal-bolus regimen with insulin aspart as bolus insulin af...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations